Free shipping on all orders over $ 500

CCT374705

Cat. No. M41958

All AbMole products are for research use only, cannot be used for human consumption.

CCT374705 Structure

Price and Availability

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

CCT374705 is an orally active BCL6 inhibitor with potent antiproliferative effects in vitro.

Chemical Information
Molecular Weight 450.84
Formula C21H18ClF3N4O2
CAS Number 2640647-90-9
Form Solid
Solubility (25°C) DMSO 100 mg/mL (Need ultrasonic)
Storage 4°C, protect from light
References

[1] Alice C Harnden et al. J Med Chem. Discovery of an In Vivo Chemical Probe for BCL6 Inhibition by Optimization of Tricyclic Quinolinones

Related Immunology/Inflammation Products
Gemtuzumab

Gemtuzumab is a monoclonal IgG4-κ antibody targeting CD33 antigen, which present on leukemic myeloblasts of acute myeloid leukemia (AML). Gemtuzumab can be used for the synthesis of antibody-drug conjugate (ADC) Gemtuzumab ozogamicin.

Cyclosporin A-d4

Cyclosporin A-d4

Mycophenolic acid-13c,d3

Mycophenolic acid-13c,d3

2-Hydroxy Fluorene

2-Hydroxy Fluorene (2-FLU) has a wide range of applications in life science related research. 2-FLU can increase the expression of psoriasis-related inflammatory factors in HaCaT cells.

Qingdainone

Qingdainone is a natural product that can be obtained from Qingdai. Qingdainone has the potential to study cancer and inflammation

  Catalog
Abmole Inhibitor Catalog




Keywords: CCT374705 supplier, Immunology/Inflammation, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.